Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
The SARS-CoV-2, the virus which is responsible for COVID-19 disease, employs its spike protein to recognize its receptor, angiotensin-converting enzyme 2 (ACE2), and subsequently enters the host cell. In this process, the receptor-binding domain (RBD) of the spike has an interface with the α1-helix...
Saved in:
Main Authors: | Sara Zareei (Author), Saeed Pourmand (Author), Massoud Amanlou (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
by: Deepa Raghu, et al.
Published: (2022) -
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022) -
A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)
by: Paolo Coghi, et al.
Published: (2021) -
Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2
by: Israa Mohamed Shamkh, et al.
Published: (2021) -
Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein-human ACE2 interaction
by: Violeta Marković, et al.
Published: (2023)